Pictet Asset Management (UK)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Pictet Asset Management (UK)’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,839	Closed	-$620K	–	1759
2021 Q1	$620K	Buy	+33,839	New	+$629K	﹤0.01%	1146
2016 Q2	–	Sell	-35,600	Closed	-$375K	–	854
2016 Q1	$375K	Hold	35,600	–	–	﹤0.01%	804
2015 Q4	$507K	Sell	35,600 -6,200	-15%	-$81.9K	﹤0.01%	814
2015 Q3	$489K	Buy	41,800 +5,400	+15%	+$81K	﹤0.01%	831
2015 Q2	$592K	Sell	36,400 -524,949	-94%	-$8.18M	﹤0.01%	831
2015 Q1	$8.12M	Buy	561,349 +543,549	+3,054%	+$7.26M	0.03%	473
2014 Q4	$207K	Hold	17,800	–	–	﹤0.01%	845
2014 Q3	$207K	Buy	+17,800	New	+$185K	﹤0.01%	835

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pictet Asset Management (UK)'s AMPH Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2021, closing a stake of 33,839 shares — an estimated $620K sold.

Pictet Asset Management (UK) first reported a position in AMPH in Q3 2014 and held it in 8 quarters. The position peaked at $8.12M in Q1 2015. 146 funds tracked by Wall St. Rank hold AMPH as of Q2 2021.

Pictet Asset Management (UK) reported no remaining Amphastar Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Pictet Asset Management (UK) sold 33,839 Amphastar Pharmaceuticals shares in Q2 2021, an estimated $620K.
Pictet Asset Management (UK) first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 8 quarters.
Pictet Asset Management (UK)'s Amphastar Pharmaceuticals position peaked at $8.12M in Q1 2015.
146 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.